Anders Grubb

Q: What Schools Are Affiliated With Anders Grubb

Anders Grubb is affiliated with the following schools: Harvard University, Stockholm University, Uppsala University, Tufts University, Lund University

Anders Grubb's AcademicInfluence.com Rankings

Anders Grubb

Physics

#4362

World Rank

#6010

Historical Rank

physics Degrees

Download Badge

Physics

Anders Grubb's Degrees

PhD Physics Uppsala University

Why Is Anders Grubb Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anders Grubb is a Swedish chemist, physician, and academic. He is currently a Senior Professor of Clinical Chemistry at Lund University. Education Grubb earned his Ph.D. degree in Clinical Chemistry in 1974 and an M.D. in 1975. Following this, he attended The New York University Medical Center as a Postdoctoral fellow in 1975, and The University Hospital Ramon y Cajal in Madrid in 1980.

(See a Problem?)

Anders Grubb's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cystatin C as a marker of GFR--history, indications, and future research. (2005) (721)
Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. (1995) (675)
Structure and expression of the human cystatin C gene. (1990) (588)
Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. (1994) (529)
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. (2021) (505)
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. (1999) (487)
Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. (2005) (472)
Renal handling of radiolabelled human cystatin C in the rat. (1996) (468)
Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. (1986) (463)
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L (2004) (427)
Low level exposure to cadmium and early kidney damage: the OSCAR study (2000) (422)
Cystatin C-Properties and use as diagnostic marker (2001) (417)
Human renal function maturation: a quantitative description using weight and postmenstrual age (2009) (402)
Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping (2001) (385)
The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. (1985) (367)
Measuring GFR: a systematic review. (2014) (352)
FGF-2-Responsive Neural Stem Cell Proliferation Requires CCg, a Novel Autocrine/Paracrine Cofactor (2000) (327)
Diagnostic value of analysis of cystatin C and protein HC in biological fluids. (1992) (320)
Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. (2009) (318)
First certified reference material for cystatin C in human serum ERM-DA471/IFCC (2010) (317)
Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. (1982) (312)
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. (1986) (285)
The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors (1984) (284)
Low‐Level Cadmium Exposure and Osteoporosis (2000) (280)
Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. (1999) (264)
Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors* (2006) (256)
Isolation and characterization of a tumor necrosis factor binding protein from urine (1989) (247)
Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. (2014) (224)
Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor (1989) (216)
Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease (2008) (204)
Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. (1979) (202)
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. (1986) (188)
Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. (1987) (185)
MUTATION IN CYSTATIN C GENE CAUSES HEREDITARY BRAIN HAEMORRHAGE (1988) (181)
Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C (1987) (180)
Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. (1997) (175)
Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins* (1997) (171)
The Increase of Plasma Homocysteine Concentrations with Age Is Partly due to the Deterioration of Renal Function as Determined by Plasma Cystatin C (1998) (171)
Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. (1995) (167)
Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus (1990) (165)
Efficient production of native, biologically active human cystatin C by Escherichia coli (1988) (162)
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. (1991) (160)
Lead Binding to δ-Aminolevulinic Acid Dehydratase (ALAD) in Human Erythrocytes (1997) (159)
Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E–Null Mice (2005) (155)
Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort (2011) (154)
Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor* (1998) (148)
A cystatin C‐based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft‐Gault formula (2005) (144)
CKD: A Call for an Age-Adapted Definition. (2019) (143)
Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. (2003) (140)
The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population (2014) (137)
Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. (1984) (136)
Structural Basis for the Biological Specificity of Cystatin C (1995) (135)
A complex-forming glycoprotein heterogeneous in charge and present in human plasma, urine, and cerebrospinal fluid. (1976) (129)
Serum cystatin C as a determinant of glomerular filtration rate in children. (1998) (127)
New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. (1994) (127)
Structural studies of cysteine proteases and their inhibitors. (2001) (124)
A tumor necrosis factor binding protein is present in human biological fluids (1988) (121)
Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. (1994) (119)
Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. (2004) (114)
Prevention of Domain Swapping Inhibits Dimerization and Amyloid Fibril Formation of Cystatin C (2004) (113)
Fibrillogenic Oligomers of Human Cystatin C Are Formed by Propagated Domain Swapping* (2007) (112)
Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. (1999) (111)
Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines (2010) (110)
Many bacterial species bind human IgD. (1979) (105)
Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy (2002) (104)
36th International Symposium on Intensive Care and Emergency Medicine (2016) (103)
Hereditary cystatin C (γ‐trace) amyloid angiopathy of the CNS causing cerebral hemorrhage (1987) (101)
Cystatin C modulates cerebral β-amyloidosis (2007) (99)
Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check (2010) (98)
3D domain‐swapped human cystatin C with amyloidlike intermolecular β‐sheets (2005) (95)
Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre‐eclamptic pregnancies (2003) (94)
Hereditary cystatin C amyloid angiopathy (2000) (92)
Serum Cystatin C Is a More Sensitive and More Accurate Marker of Glomerular Filtration Rate than Enzymatic Measurements of Creatinine in Renal Transplantation (2003) (92)
The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models (2006) (90)
The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. (1984) (89)
Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. (1990) (87)
Prediction of relative glomerular filtration rate in adults: New improved equations based on Swedish Caucasians and standardized plasma‐creatinine assays (2007) (87)
Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone‐related peptide of malignancy (1992) (87)
Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy (2004) (84)
Cathepsin B Degrades Amyloid-β in Mice Expressing Wild-type Human Amyloid Precursor Protein* (2012) (83)
Cystatin C modulates cerebral beta-amyloidosis. (2007) (81)
Standardization of Cystatin C: Development of primary and secondary reference preparations (2008) (81)
Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. (1987) (81)
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation (2011) (79)
Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. (1993) (79)
Crystal structure of human cystatin C stabilized against amyloid formation (2010) (79)
Human gamma-trace. Structure, function and clinical use of concentration measurements. (1985) (78)
Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice (2005) (76)
High-level expression of active human cystatin C in Escherichia coli. (1989) (76)
Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli (1991) (76)
Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’ (2015) (75)
Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden (2015) (75)
Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration. (1983) (75)
Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine (2011) (75)
Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. (2001) (74)
The Protease Inhibitor Cystatin C Is Differentially Expressed among Dendritic Cell Populations, but Does Not Control Antigen Presentation 1 (2003) (73)
Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. (1991) (72)
Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. (1993) (72)
Temporal changes of the plasma levels of cystatin C, β‐trace protein, β2‐microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process (2007) (70)
Stability of albumin, protein HC, immunoglobulin G, K- AND γ-chain immunoreactivity, orosomucoid and a 1-antitrypsin in urine stored at various conditions (1994) (70)
Cystatin C reduces the in vitro formation of soluble Aβ1‐42 oligomers and protofibrils (2007) (70)
Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. (1988) (70)
Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR. (1994) (68)
Domain swapping in N-truncated human cystatin C. (2004) (68)
Inhibitory effects of recombinant human cystatin C on human coronaviruses (1991) (67)
Cystatin C, and inhibitor of bone resorption produced by osteoblasts. (1997) (65)
Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, k- and Δ-immunoreactivity, orosomucoid and α1-antitrypsin (1996) (65)
Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. (1997) (64)
Isolation and some properties of an IgG Fc-binding protein from group A streptococci type 15. (1982) (63)
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration (1998) (63)
Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse (2005) (62)
Cystatin C, β‐2‐microglobulin and β‐trace protein in pre‐eclampsia (2007) (60)
Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. (1990) (60)
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. (1997) (60)
Structural basis for different inhibitory specificities of human cystatins C and D. (1998) (59)
Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. (1996) (58)
Long-term Stability of Albumin, Protein HC, Immunoglobulin G, κ- and λ-chain-immunoreactivity, Orosomucoid and α1-antitrypsin in Urine Stored at -20°C (1997) (58)
The molecular organization of the protein HC-IgA complex (HC-IgA). (1986) (57)
Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. (1986) (55)
Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. (2010) (53)
Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. (2001) (52)
HUMAN BRAIN CORTICAL NEURONS CONTAIN y-TRACE. RAPID ISOLATION, IMMUNOHISTOCHEMICAL AND PHYSICOCHEMICAL CHARACTERIZATION OF HUMAN y- TRACE (1981) (52)
Cloning and sequencing of a cDNA encoding rat d‐dopachrome tautomerase (1995) (50)
Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting (2016) (50)
Osteoclastogenesis is decreased by cysteine proteinase inhibitors. (2004) (50)
Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note. (1998) (49)
The CKD-EPI and MDRD equations to estimate GFR. Validation in the Swedish Lund-Malmö Study cohort (2011) (49)
Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations (2009) (48)
Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases. (1994) (48)
AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. (1990) (46)
The disulphide bridges of human cystatin C (γ‐trace) and chicken cystatin (1984) (46)
Pre-analytical factors influencing the stability of cerebrospinal fluid proteins (2013) (45)
DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level (2004) (45)
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids (2001) (45)
Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. (1992) (43)
Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C. (1990) (42)
The Lund–Malmö creatinine‐based glomerular filtration rate prediction equation for adults also performs well in children (2008) (42)
Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis (1992) (41)
Ig-binding bacterial proteins also bind proteinase inhibitors. (1989) (41)
The complete amino acid sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC) from one individual. (1984) (41)
Albumin adducts in plasma from workers exposed to toluene diisocyanate. (1997) (40)
Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children (2019) (40)
Production of protein HC by human fetal liver explants. (1978) (39)
Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse (2004) (39)
Different Cysteine Proteinases Involved in Bone Resorption and Osteoclast Formation (2005) (39)
Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. (1996) (39)
Application of liquid chromatography–inductively coupled plasma mass spectrometry to the study of protein-bound lead in human erythrocytes (1996) (39)
Serum Amyloid A Protein and C-Reactive Protein in Normal Pregnancy and Preeclampsia (2009) (38)
Determination of allotypes G1m(f) and G1m(z) at the genomic level by subclass-specific amplification of DNA and use of allele-specific probes. (1991) (38)
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate (2020) (37)
Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. (2002) (37)
Quantitation of J chain in human biological fluids by a simple immunochemical procedure. (2009) (36)
Standardization of p‐creatinine assays and use of lean body mass allow improved prediction of calculated glomerular filtration rate in adults: A new equation (2006) (35)
Cystatin C is Indispensable for Evaluation of Kidney Disease (2017) (35)
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. (2005) (35)
The complete amino acids sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC). (1981) (35)
Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome (2017) (34)
Isolation of rat serum alpha 1-microglobulin. Identification of a complex with alpha 1-inhibitor-3, a rat alpha 2-macroglobulin homologue. (1990) (34)
The protein HC chromophore is linked to the cysteine residue at position 34 of the polypeptide chain by a reduction-resistant bond and causes the charge heterogeneity of protein HC. (1991) (34)
Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C: validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort (2018) (34)
Different elimination patterns of β‐trace protein, β2‐microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration (2008) (34)
Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus (1996) (34)
Immunocapillarymigration--a new method for immunochemical quantitation. (1978) (34)
Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins (2018) (34)
A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro. (2000) (34)
Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. (1987) (33)
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. (1998) (33)
Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. (2020) (32)
The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population – the HARVEST study (2016) (32)
Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature. (2009) (31)
GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults (2017) (31)
The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome (2018) (31)
Governing the monomer-dimer ratio of human cystatin c by single amino acid substitution in the hinge region. (2009) (31)
Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1 (1984) (31)
Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities (2020) (30)
Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. (1994) (30)
The amino terminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated: direct sequence analysis from agarose gel electropherograms. (1990) (29)
Location and characterization of the three carbohydrate prosthetic groups of human protein HC (1990) (29)
Regulation of cystatin C activity by serine proteinases. (1991) (29)
Quantitation of immunoglobulin G by electrophoresis in agarose gel containing antibodies. (1970) (29)
New antimicrobial cystatin C‐based peptide active against gram‐positive bacterial pathogens, including methicillin‐resistant Staphylococcus aureus and multiresistant coagulase‐negative staphylococci (2003) (27)
Mutation in the cystatin C gene causes hereditary brain hemorrhage. (1989) (27)
Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling (2013) (27)
C-reactive protein levels following standard neurosurgical procedures (2003) (27)
Age-related reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC in children (2000) (27)
Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: why is the L68Q variant amyloidogenic? (2006) (27)
Expression of a selenomethionyl derivative and preliminary crystallographic studies of human cystatin C (1999) (26)
Immunocapillarymigration with enzyme-labeled antibodies: rapid quantification of C-reactive protein in human plasma. (1981) (26)
Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice (2010) (26)
The activation, purification and properties of rat pancreatic juice phospholipase A 2. (1971) (25)
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes (2006) (25)
The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio (2019) (24)
Performance evaluation of a turbidimetric cystatin C assay on different high-throughput platforms (2010) (24)
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. (2007) (24)
Renal impairment after hip or knee arthroplasty. Urinary excretion of protein markers studied in 59 patients. (1997) (24)
Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex. (1994) (23)
Inhibition of lipopolysaccharide‐induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors (2017) (22)
Preparation of electroendosmosis-free agarose gel and exemplification of its use in crossed immunoelectrophoresis. (1973) (21)
Elevated infection parameters and infection symptoms predict an acute coronary event (2008) (21)
The γ-trace concentration of normal human seminal plasma is thirty-six times that of normal human blood plasma (1983) (21)
Distribution of cystatin C (gamma-trace), an inhibitor of lysosomal cysteine proteinases, in the anterior lobe of simian and human pituitary glands. (1985) (20)
An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism (1993) (20)
In vivo XRF as a means to evaluate the risk of kidney effects in lead and cadmium exposed smelter workers. (1998) (20)
Interference of immunoglobulins in two glucagon radioimmunoassays. (1982) (19)
Expression of protein HC on the plasma membrane of different human cell types. (1977) (19)
Increased plasma levels of ß2‐microglobulin, cystatin C and ß‐trace protein in term pregnancy are not due to utero‐placental production (2008) (19)
Crossed immunoelectrophoresis and electroimmunoassay of IgG. (1974) (18)
Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis. (1997) (18)
Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy–related hemorrhage (2000) (18)
Cystatin C mutation causing amyloid angiopathy and brain hemorrhage. (1990) (18)
Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C (2014) (17)
Immunofluorescent demonstration of the presence of protein HC on the surface of human lymphocytes. (2009) (17)
Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development (2011) (17)
A sensitive and rapid enzyme-linked immunosorbent assay using monoclonal antibodies for simultaneous quantitation of free and IgA-complexed protein HC. (1985) (17)
Stabilization, Characterization, and Selective Removal of Cystatin C Amyloid Oligomers* (2013) (17)
Immunochemical quantitation of IgG: influences of the antiserum and of the antigenic population. (1973) (17)
A novel method for creatinine adjustment makes the revised Lund–Malmö GFR estimating equation applicable in children (2020) (16)
DEMONSTRATION OF SEPARATE RECEPTORS FOR HUMAN IgA AND IgG IN GROUP A STREPTOCOCCI TYPE (1980) (16)
Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate (2009) (16)
Analysis of the immunochemical relationship between antigens by electrophoresis in agarose gels containing antibodies. (1972) (16)
Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients. (1984) (16)
A Rapid Enzyme-Linked Immunosorbent Assay for Serum Amyloid a Using Sequence-Specific Antibodies (1993) (16)
Isolation and partial characterization of a low molecular weight trypsin inhibitor from human urine. (1981) (16)
Immunochemical evidence for a common variable region in three immunoglobulin classes in the same individual. (1975) (16)
Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine (2017) (16)
Human protein HC displays variability in its carboxyl‐terminal amino acid sequence (1982) (15)
Occurrence of γ-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma (1983) (15)
Intracellular distribution of lipase in comparison to trypsinogen, amylase and immediately measureable trypsin inhibitors in the rat pancreas. (1969) (15)
Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases. (1997) (15)
Renal tubular dysfunction after urinary diversion. (1995) (15)
DEMONSTRATION OF y-TRACE IN NORMAL AND NEOPLASTIC ENDOCRINE A-CELLS OF THE PANCREATIC ISLETS: AN IMMUNOHISTOCHEMICAL STUDY IN MONKEY, RAT AND MAN (1981) (15)
Family 2 cystatins inhibit osteoclast-mediated bone resorption in calvarial bone explants. (2004) (15)
Accurate eGFR reporting for children without anthropometric data. (2017) (15)
Identification of retinol as one of the protein HC chromophores. (1988) (15)
Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells (2017) (15)
Demonstration of the non-identity between the Fc receptor for human IgG from group A streptococci type 15 and M protein, peptidoglycan and the group specific carbohydrate. (1979) (15)
Interaction of serum amyloid A with human cystatin C—identification of binding sites (2012) (14)
Synthesis and antibacterial properties of peptidyl derivatives and cyclopeptides structurally based upon the inhibitory centre of human cystatin C: Dissociation of antiproteolytic and antibacterial effects (2000) (14)
The Crystal Structure of Glutarimide. (1971) (13)
Production of an amino acid sequence-specific antiserum against human amyloid A (AA) and serum amyloid A (SAA) protein. (1987) (13)
Lowered levels of serum albumin and HDL‐cholesterol in children with a recent mild infection (2006) (13)
Affinity screening for weak monoclonal antibodies. (1998) (12)
The homing endonuclease I-CreI uses three metals, one of which is shared between the two active sites (2001) (12)
Performance of creatinine‐based equations to estimate glomerular filtration rate with a methodology adapted to the context of drug dosage adjustment (2021) (12)
Crossed immunoelectrophoresis and electroimmunoassay of IgM. (1974) (12)
Biomarkers of nephrotoxicity in children environmentally exposed to lead in Poland (1999) (12)
New antimicrobial peptide active against Gram-positive pathogens. (2004) (12)
The amino‐terminal sequence of human protein HC (1976) (12)
Comparative study of Helicobacter pylori infection in guinea pigs and mice - elevation of acute-phase protein C3 in infected guinea pigs. (2001) (12)
Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. (2004) (11)
Factors influencing analysis of prolyl endopeptidase in human blood and cerebrospinal fluid: increase in assay sensitivity (2003) (11)
Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation. (2015) (11)
MUTATION IN THE CYSTATIN C GENE CAUSES HEREDITARY CYSTATINC AMYLOID ANGIOPATHY WITH CEREBRAL HEMORRHAGE (1988) (11)
Urine IgG2/IgG4-ratio indicates the significance of the charge selective properties of the glomerular capillary wall for the macromolecular transport in glomerular diseases. (1999) (11)
A sequence variation in the human cystatin D gene resulting in an amino acid (Cys/Arg) polymorphism at the protein level (1993) (11)
Interaction between streptococcal protein Arp and different molecular forms of human immunoglobulin A. (1994) (11)
Inaccuracy of GFR predictions by plasma cystatin C in patients without kidney dysfunction and in advanced kidney disease. (2008) (11)
Cystatin C: a new marker of biocompatibility or a good marker for the redistribution of LMW proteins during hemodialysis? (1988) (11)
The cerebrospinal fluid and plasma concentrations of γ-trace and β2-microglobulin at various ages and in neurological disorders (2004) (10)
Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine (2016) (10)
A New Method for Immunochemical Quantification (1977) (10)
Safer proteinase treatment of sciatica. A biochemical preview of chymopapain inhibitors. (1988) (10)
First International Reference Preparation for Individual Proteins in Urine. IFCC Working Group on Urine Proteins. International Federation of Clinical Chemistry. (1998) (10)
Variability in diagnostic accuracy can be estimated using simple population weighting. (2009) (10)
Spectroscopic characterization by photodiode array detection of human urinary and amniotic protein HC subpopulations fractionated by anion-exchange and size-exclusion high-performance liquid chromatography. (1996) (9)
Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at -20 degrees C. (1997) (9)
Assignment of allotypes G1m(a+) and G1m(a-) at the genomic level by polymerase chain reaction analysis. (1990) (9)
Interaction of the Fc part of IgG with Lancefield extracts of hemolytic streptococci. Strain specificity and activity. (1979) (9)
A novel mutation in the β-protein coding region of the amyloid β-protein precursor (APP) gene (1992) (9)
The prevalence of renal amyloidosis of the AA-type in a series of 1,158 consecutive autopsies. (2009) (9)
Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B (2008) (9)
Accuracy diagrams: a novel way to illustrate uncertainty of estimated GFR (2017) (9)
The domain swapping of human cystatin C induced by synchrotron radiation (2019) (9)
Estimating GFR prior to contrast medium examinations—what the radiologist needs to know! (2016) (9)
Synthesis and antibacterial properties of peptidyl derivatives and cyclopeptides structurally based upon the inhibitory centre of human cystatin C. Dissociation of antiproteolytic and antibacterial effects. (2000) (9)
Dry-reagent double-monoclonal assay for cystatin C. (2010) (9)
High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy (2011) (8)
Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells. (2017) (8)
Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type. (2009) (8)
Prospects for improved glomerular filtration rate estimation based on creatinine—results from a transnational multicentre study (2020) (8)
Performance of Indexed and Nonindexed Estimated GFR. (2020) (8)
Human complex-forming glycoprotein, heterogeneous in charge: the primary structure around the cysteine residues and characterization of a disulfide bridge. (1982) (8)
Potential Relationship Between eGFRcystatin C/eGFRcreatinine-ratio and Glomerular Basement Membrane Thickness in Diabetic Kidney Disease (2020) (8)
Oligoclonal IgG bands synthesized in the central nervous system are present in rats with experimental autoimmune encephalomyelitis (2004) (8)
Cystatin C as a Biomarker in Kidney Disease (2011) (8)
Renal dysfunction after total knee replacement is not aggravated by bone cement (1998) (8)
Demonstration of sequence variations in the promoter region of the human cystatin C gene. (1992) (7)
Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients (2021) (7)
A new tool for predicting the probability of chronic kidney disease from a specific value of estimated GFR (2010) (7)
Accuracy of GFR estimating equations in a large Swedish cohort: implications for radiologists in daily routine and research (2017) (7)
Notable steps in obtaining improved estimates for glomerular filtration rate. (2006) (7)
Development of monoclonal antibodies against creatine kinase MB2 (2002) (7)
No effect of diclofenac on the pharmacokinetics of cloxacillin. (1997) (7)
Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections. (2017) (7)
Glomerular filtration and shrunken pore syndrome in children and adults (2021) (7)
Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis (2020) (7)
Quantitative Crossed Immunoelectrophoresis—A Convenient Procedure for the Simultaneous Quantitation of Various Molecular Forms of an Antigen (1983) (7)
Potential relationship between eGFRcystatin C/eGFRcreatinine‐ratio and glomerular basement membrane thickness in diabetic kidney disease (2021) (6)
The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders. (1980) (6)
Rheumatoid Arthritis – A Gene Transfer Disease (1999) (6)
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil, and Africa. (2022) (6)
Screening for weak monoclonal antibodies in hybridoma technology (1998) (6)
Comparative study of Helicobacter pylori infection in guinea pigs and mice - elevation of acute-phase protein C3 in infected guinea pigs (2001) (6)
Protein HC‐IgA Complexes Carry Antibody Activities (1988) (6)
Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients (2009) (6)
Demonstration of Circulating IgG‐Lactate Dehydrogenase Immune Complexes by Crossed Immunoelectrophoresis (1975) (5)
Occurrence of gamma-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma. (1983) (5)
Cystatin C as a Multifaceted Biomarker in Kidney Disease and Its Role in Defining “Shrunken Pore Syndrome” (2017) (5)
The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST‐Malmö study (2021) (5)
Markers of renal function at admission and mortality in hip fracture patients - a single center prospective observational study (2021) (5)
Nt‐proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients (2005) (5)
The gamma-trace concentration of normal human seminal plasma is thirty-six times that of normal human blood plasma. (1983) (5)
γ-Trace in Human Pituitary Adenomas* (1984) (5)
Two new types of assays to determine protein concentrations in biological fluids using mass spectrometry of intact proteins with cystatin C in spinal fluid as an example (2014) (4)
Quantitative determination of the distribution of the specific antibodies of antisera subjected to gel electrophoresis. (1972) (4)
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis - A post-hoc analysis of the FINNAKI cohort. (2022) (4)
The identification of discontinuous epitope in the human cystatin C - Monoclonal antibody HCC3 complex. (2019) (4)
An Isolate of Families with Hereditary Cystatin C Amyloid Angiopathy and Cerebral Haemorrhage in the South of Iceland (1988) (4)
The Modified CKiD Study Estimated GFR Equations for Children and Young Adults Under 25 Years of Age: Performance in a European Multicenter Cohort. (2022) (3)
Errors in the Assessment of Estimated Glomerular Filtration Rate: Reply (2006) (3)
Cystatin C-based equations for estimating glomerular filtration rate do not require race or sex coefficients (2022) (3)
Cyclic trimer of human cystatin C, an amyloidogenic protein - molecular dynamics and experimental studies (2018) (3)
Large difference but high correlation between creatinine and cystatin C estimated glomerular filtration rate in Mesoamerican sugarcane cutters (2022) (3)
244. Predicting maternal morbidity in hypertension in pregnancy with the ‘shrunken pore syndrome’ ratio for optimal timing of delivery (2018) (3)
The Use of Enzyme-labeled Antibodies to Increase the Sensitivity of Immunocapillarymigration. (1980) (3)
Microcalorimetric studies on uraemic plasma. (1992) (3)
Three RFLPs at the 3' end of the cystatin C gene, the disease gene in hereditary cystatin C amyloid angiopathy (HCCAA) in Iceland. (1990) (3)
Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex. (2023) (2)
Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective. (2021) (2)
The first step in creating national Chronic Kidney Disease (CKD) guidelines – a questionnaire (2019) (2)
Quantification of cystatin C by time-resolved fluorometry-based immunoassays. (2012) (2)
gamma-trace in human pituitary adenomas. (1984) (2)
SAXS studies of human protein HC (alpha1-microglobulin). (2007) (2)
Overall conformation of covalently stabilized domain-swapped dimer of human cystatin C in solution (2017) (2)
Cystatin C (α-trace) amyloidosis (1986) (2)
Structural Characterization of Covalently Stabilized Human Cystatin C Oligomers (2019) (2)
Bacteria-immunoglobulin-lymphocyte interactions--new aspects. (1980) (2)
N-Truncated Human Cystatin C; Dimeric Form With 3D Domain Swapping (2004) (2)
Recent developments in the chemistry and biology of cystatins (1993) (2)
Massive glycation of protein HC, a low molecular weight lipocalin, in non‐diabetic individuals (1997) (2)
Neutral microprotein, a novel human plasma and urinary protein associated with a yellow-brown chromophore. Isolation from protein HC preparations and partial characterization. (1983) (2)
Cystatin C- and creatinine-based GFR-prediction equations for children and adults. (2011) (2)
Cystatin C: More than a renal function marker. (2015) (2)
Absorption of Human Plasma on Protein A-Sepharose: Effects on in Vitro Parameters of Tumor Immunity1 (1982) (2)
[Time for new measurements in kidney disease diagnosis and follow-up]. (2013) (2)
Effect of antisense peptide binding on the dimerization of human cystatin C--gel electrophoresis and molecular modeling studies. (2004) (2)
Paper electrophoretic and immunochemical quantitation of IgG M-components in serum. (1970) (2)
Effects of plasmapheresis on the plasma concentration of proteins used to monitor the disease process in multiple myeloma. (2009) (1)
MO385: Performance of Creatinine-Based Equations to Estimate Glomerular Filtration Rate in White and Black Subjects From Europe, Brazil and Africa (2022) (1)
Production of Cystatin C Wild Type and Stabilized Mutants (2010) (1)
In Search of Selective Inhibitors of Cysteine Protease, Cathepsin K (2005) (1)
Crossed Immunoelectrophoresis (1983) (1)
damage: the OSCAR study (2000) (1)
Cystatin-like domains of LMW-kininogen, and speculations on the evolution of cystatins (1986) (1)
Peptidyl diazomethylketones as cysteine protease inhibitors structurally based upon the inhibitory centers of cystatins (2001) (1)
An efficient E. coli expression system for human cystatin C: Production and characterization of the native and N-terminally Ala-Met-Glu-Ala-Glu-extended inhibitor (1989) (1)
Cystatin C inhibits osteoclast formation and activation via different mechanisms (2001) (1)
Measurement of oxygen consumption and heat production in plasma from uremic patients on chronic dialysis treatment (1995) (1)
Combined Use of Electroendosmosis-free Agarose Gel and Polyacrylamide Gel in some Electrophoretic Procedures (1974) (1)
A new method for immunochemical quantification [proceedings]. (1977) (1)
The impact of human cystatin C hinge loop L1 on its dimerization and oligomerization propensity (2008) (1)
The dispersion of water proton spin-lattice relaxation rates in aqueous human protein HC (alpha1-microglobulin) solutions. (2009) (1)
Peptide compound and produced through this connection antiserum. (1986) (0)
Escherichia coli . nucleotide sequence , and expression in protein of Haemophilus influenzae : cloning , Protein D , an immunoglobulin D-binding (2003) (0)
Molecular Biology of Hereditary Cystatin C Amyloid Angiopathy in Iceland (1991) (0)
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. (1992) (0)
Seen detecting an antigen in the sample of example kroppvetskor, using the porous adsorbent or berarmaterial bound antibodies (1975) (0)
Characteristics of hCC-mAb complex (2010) (0)
ORIGINAL ARTICLE The Lund-Malmocreatinine-based glomerular filtration rate prediction equation for adults also performs well in children (2008) (0)
Diagnostic devices and methods for performing quantitative immunochemical regulations (1976) (0)
Low-resolution structure in solution and amyloidogenesis of human cystatin C (2011) (0)
Morphology of Human Cystatin C Oligomers - Towards the Construction of Hcc Nanodetector (2019) (0)
The domain swapping of human cystatin C induced by synchrotron radiation (2019) (0)
HC‐IgA antibodies of different specificities are normally present in serum: quantitation by ELISA and relationship to the major Ig classes (1990) (0)
P3-212 CATABOLISM OF ALZHEIMER’S AMYLOID-b: IMPLICATIONS FOR BRAIN CLEARANCE AND PLAQUE DEPOSITION (2010) (0)
simplex virus type 1. specificity of Fc receptors induced by herpes Human immunoglobulin class and subclass (2013) (0)
HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING (2001) (0)
Cysteine proteinase inhibitors decrease rankl and lps induced differentiation of human and mouse osteoclast progenitor cells (2012) (0)
Preanalytical factors influencing the cerebrospinal fluid proteome (2010) (0)
HumanImmunoglobulin Class andSubclass Specificity ofFc Receptors Induced byHerpesSimplex Virus Type1 (1984) (0)
Procede de production de cystatine c ou modifications de la cystatine et sequence d'adn destinee a etre utilisee lors de la realisation dudit procede (1988) (0)
Peptidyl aldehydes based on N-terminal binding fragments of cystatins as thioprotease inhibitors (2001) (0)
Interference of immunoglobulins in two glucagon radioimmunoassays. [Blood donor and patient immunoglobulins] (1982) (0)
First symposium on hereditary central nervous system amyloid angiopathy. September 2–3, 1985, Reykjavík, Iceland (1986) (0)
Chapter 27. Cystatin C (2008) (0)
Photophysical properties of human cystatin C (1993) (0)
Structure of HCC oligomers - SAXS and MD studies (2013) (0)
United States Patent ( 19 ) Grubb et al . ( 54 ) RECOMBINANT 3-DES-OH-CYSTATIN C (2017) (0)
Cystatin C,a HumanProteinase Inhibitor, BlocksReplication ofHerpesSimplex Virus (1990) (0)
[GFR estimation in children - age-adjusted creatinine makes the adult Lund-Malmö equation applicable in children and facilitates automatic GFR reporting from the clinical laboratory]. (2021) (0)
Inhibition of experimental poststreptococcal glomerulonephritis in rabbits by IgG Fc fragments (2006) (0)
P1-097 The role of cystatin C in cerebral amyloidosis: New insights from transgenic mouse models (2006) (0)
Crystal structure of monomeric human cystatin C stabilized against aggregation (2010) (0)
Studies on the Cystatin C Gene in Patients with Hereditary Cystatin C Amyloid Angiopathy (HCCAA) with Cerebral Haemorrhage (1988) (0)
Cysteine proteinases in osteoclast function and recruitment (2004) (0)
IgM-Levels from Cord Sera and their Relation to Infections During Pregnancy (1971) (0)
[Shrunken Pore Syndrome - a new syndrome]. (2019) (0)
60 Changed renal function after pregnancy both with and without a hypertensive disorder (2016) (0)
PROCEDURE and diagnostic agent for immunochemical kvantifecering (1976) (0)
Inhibition of lipopolysacharide induced osteoclast formation and bone resorption in vitro and in vivo in mice by cystatin C (2013) (0)
Domain-swapping dimerization of human cystatin C (2000) (0)
Multicenter evaluation of a new turbidimetric Cystatin C assay for use on cobas c, Roche/Hitachi and COBAS INTEGRA (R) systems (2008) (0)
Inhibitory Effects ofRecombinant HumanCystatin C on HumanCoronaviruses (1991) (0)
Screening for weak monoclonal antibodies in hybridoma technology. (1998) (0)
O 2 . 2 Bacterial members of HtrA serine proteases family – important virulence factors and interesting models for structural studies (2011) (0)
Correction to: Estimating GFR prior to contrast medium examinations—what the radiologist needs to know! (2021) (0)
Author's Reply (2004) (0)
STRUCTURAL STUDIES OF COVALENTLY STABILISED OLIGOMERS OF HUMAN CYSTATIN C (2012) (0)
Structure-activity relationship studies for Cystapep 1 and its analogues (2010) (0)
Search of synthetic low-molecular peptide derivatives with activity against fungal pathogens (2006) (0)
[Use cystatin C-based GFR-estimating equations]. (2022) (0)
Reduced renal elimination of larger molecules is a strong predictor for mortality (2022) (0)
MO131THE SHRUNKEN PORE SYNDROME IS ASSOCIATED WITH POOR PROGNOSIS AND LOWER QUALITY OF LIFE IN HEART FAILURE PATIENTS- THE HARVEST-MALMÖ STUDY (2021) (0)
Synthesis and SAR Studies of Antibacterial Peptidyl Derivatives Based upon the Binding Site of Human Cystatin C. (2019) (0)
and others Genomic Southern blotting and hybridization Genomic DNA was isolated from human blood cells (2005) (0)
Procedure for the immunochemical quantitative determination of an antigen (1976) (0)
Gene expression studies in platinum-resistant testicular germ cell tumours (2019) (0)
Muscle mass, creatinine, cystatin C, and selective glomerular hypofiltration syndromes (2023) (0)
Inhibition of cysteine proteinases by a series of peptidyl-diazomethanes structurally related to the binding center of cystatins (1991) (0)
MO071PROTEINS LINKED TO ATHEROSCLEROSIS AND CELL PROLIFERATION ARE ASSOCIATED WITH SHRUNKEN PORE SYNDROME IN HEART FAILURE PATIENTS (2021) (0)
MO071 PROTEINS LINKED TO ATHEROSCLEROSIS AND CELL PROLIFERATION ARE ASSOCIATED WITH SHRUNKEN PORE SYNDROME IN HEART FAILURE PATIENTS (2021) (0)
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function (2022) (0)
The first harmonization step on cystatin C, with the aim to introduce the first ERM-DA471/IFCC cystatin C calibrator and one worldwide company-independent EGFR equation (2011) (0)
4P-1131 Absence of the protease inhibitor cystatin C in bone marrow cells results in increased plaque size and increased elastin staining in apolipoprotein E deficient mice (2003) (0)
Corrigendum to: Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden (2016) (0)
Contents Vol. 67, 2009 (2009) (0)
The complexity of kidney disease and diagnosing it – cystatin C, selective glomerular hypofiltration syndromes and proteome regulation (2022) (0)

This paper list is powered by the following services:

Other Resources About Anders Grubb

en.wikipedia.org

What Schools Are Affiliated With Anders Grubb?

Anders Grubb is affiliated with the following schools:

Anders Grubb's Academic­Influence.com Rankings